参考文献
[1]Freddie B M,Jacques F M,Isabelle S I,et al.Global cancer statistic 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018(68):394-424.
[2]陈万青，郑荣寿，张思维，等.2012年中国恶性肿瘤发病和死亡分析[J].中国肿瘤，2016（5）：1-8.
[3]李琎，吴小华.宫颈癌保留生育功能的腹式根治性宫颈切除术——一项潜在获益人群的研究[J].中国癌症杂志，2012，22（6）：407-412.
[4]NCCN clinical practice guidelines in Oncology:cervical cancer(2017.V1).
[5]Jemal A,Bray F,Center M M,et al.Global cancer statistics[J].CA Cancer J Clin,2011(61):69-90.
[6]Patel S,Liyanage S H,Sahdev A,et al.Imaging of endometrial and cervical cancer[J].Insights Imaging,2010,1:309-328.
[7]Pecorelli S,Zigliani L,Odicino F.Revised FIGO staging for carcinoma of the cervix[J].Int J Gynaecol Obstet,2009(105):107-108.
[8]Downey K,Jafar M,Attygalle A D,et al.Influencing surgical management in patients with carcinoma of the cervix using a T2- and ZOOM-diffusion-weighted endovaginal MRI technique[J].Br J Cancer,2013(109):615-622.
[9]Lakhman Y,Akin O,Park K J,et al.Stage IB1 cervical cancer:role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy[J].Radiology,2013(269):149-158.
[10]殷蔚伯，余子豪，徐国镇，等.肿瘤放射治疗学[M].北京：中国协和医科大学出版社，2018，316-318.
[11]Woo S,Kim H S,Chung H H,et al.Early stage cervical cancer:role of magnetic resonance imaging after conization in determining residual tumor[J].Acta Radiol,2016(57):1268-1276.
[12]Kato T,Takashima A,Kasamatsu T,et al.Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer(JCOG0806-A)[J].Gynecol Oncol,2015(137):34-39.
[13]Cormier B,Diaz J P,Shih K,et al.Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer[J].Gynecol Oncol,2011(122):275-280.
[14]Wu Y,Li Z,Wu H,et al.Sentinel lymph node biopsy in cervical cancer:A metaanalysis[J].Mol Clin Oncol,2013(1):1025-1030.
[15]Taylor A,Rockall A G,Reznek R H,et al.Mapping pelvic lymph nodes:guidelines for delineation in intensity-modulated radiotherapy[J].Int J Radiat Oncol Biol Phys,2005,63(5):1604-1612.
[16]Lim K,W Small,Jr.,Portelance L,et al.Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer[J].Int J Radiat Oncol Biol Phys,2011,79(2):348-355.(https://www.daowen.com)
[17]Haie-Meder C,Potter R,Van Limbergen E,et al.Recommendations from Gynaecological(GYN)GEC-ESTRO Working Group(I):concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV[J].Radiother Oncol,2005,74(3):235-245.
[18]龙行涛，周琦.局部晚期宫颈癌治疗现状与进展[J].中国实用妇科与产科杂志，2017，11（33）：1206-1209.
[19]Dimopoulos J C,Petrow P,Tanderup K,et al.Recommendations from Gynaecological(GYN)GEC-ESTRO Working Group(IV):Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy[J].Radiother Oncol,2012,103(1):113-122.
[20]Wo J Y,Viswanathan A N.Impact of radiotherapy on fertility,pregnancy,and neonatal outcomes in female cancer patients[J].Int J Radiat Oncol Biol Phys,2009(73):1304-1312.
[21]Kadkhodayan S,Hasanzadeh M,Treglia G,et al.Sentinel node biopsy for lymph nodal staging of uterine cervix cancer:a systematic review and meta-analysis of the pertinent literature[J].Eur J Surg Oncol,2015(41):1-20.
[22]Mendivil A A,Rettenmaier M A,Abaid LN,et al.Survival rate comparisons amongst cervical cancer patients treated with an open,robotic-assisted or laparoscopic radical hysterectomy:A five year experience[J].Surg Oncol,2016(25):66-71.
[23]Bats A S,Frati A,Mathevet P,et al.Contribution of lymphoscintigraphy to intraoperative sentinel lymph node detection in early cervical cancer:Analysis of the prospective multicenter SENTICOL cohort[J].Gynecol Oncol,2015(137):264-269.
[24]Peters W A,Liu P Y,Barrett R J,et al.Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix[J].J Clin Oncol,2000(18):1606-1613.
[25]Monk B J,Wang J,Im S,et al.Rethinking the use of radiation and chemotherapy after radical hysterectomy:a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial[J].Gynecol Oncol,2005(96):721-728.
[26]Yoneda J Y,Braganca J F,Sarian L O,et al.Surgical treatment of microinvasive cervical cancer:analysis of pathologic features with implications on radicality[J].Int J Gynecol Cancer,2015(25):694-698.
[27]Wolfson A H,Varia M A,Moore D,et al.ACR Appropriateness Criteria(R)role of adjuvant therapy in the management of early stage cervical cancer[J].Gynecol Oncol,2012(125):256-262.
[28]Atri M,Zhang Z,Dehdashti F,et al.Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer:Results of ACRIN6671/GOG0233 trial[J].Gynecol Oncol,2016(142):413-419.
[29]Kokka F,Bryant A,Brockbank E,et al.Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer[J].Cochrane Database Syst Rev,2015(4):CD010260.
[30]Tewari K S,Sill M W,Long H J,et al.Improved survival with bevacizumab in advanced cervical cancer[J].N Engl J Med,2014(370):734-743.
[31]Balleyguier C,Fournet C,Ben H W,et al.Management of cervical cancer detected during pregnancy:role of magnetic resonance imaging[J].Clin Imaging,2013(37):70-76.
[32]Amant F,Halaska M J,Fumagalli M,et al.Gynecologic cancers in pregnancy:guidelines of a second international consensus meeting[J].INT J GYNECOL CANCER,2014(24):394-403.